Sold half at 1.8 but chart look good
$Adverum Biotechnologies(ADVM.US$ 2 insiders buy 200k cash in private placement, settlement Feb 8 the data release day. Lol, simple insider trading. Are they stupid? Anyway, there won’t be surprise for the data release, should be safe pass.
Just I am afriad the 1.2 private offering deal (typically 20% to 10% off to fair value) will pin the price to 1.4 to 1.6 area. Cashless warrant is bad for common investors. Also attract too many day traders. won’t last long unless the experiment really hits target well. My average cost like 1.5, hold for 3 years, have to do something. This is still a 5 to 10 dollar stock.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
QianmengYuOP : so strange. If insider knew data is so great, they won’t finance at 1.2 with almost 100% dilution, Private placement will get 50% shares thereafter, insider get somewhat. That’s more shares than they can dump to open market. what’s point to pump to 2.8? I don’t think in current US regulations, someone can take over a company simply just by private share issuing and collecting sufficient shares on open market (allowed in some countries).
Let’s see.